US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Magle Group to BioStock: We live by the mantra ‘earn it before you burn it’

Yesterday, Magle Group released their Q4 report showing a notable increase in revenue, underpinned by organic growth as well as the integration of two key acquisitions: PK Chemical and Amniotics. As the company continues to expand its footprint within specialty pharma and medtech, the latest quarter offers a glimpse into the early effects of these strategic moves. BioStock invited CFO Aaron Wong to the studio to tell us more about the report.See the full interview at biostock.se : https://www.biostock.se/en/2025/03/magle-group-we-live-by-the-mantra-earn-it-

BioStock: Magle Group launches multicenter trial with pancreatic leakage indicator

Magle Group has partnered with Heidelberg University Hospital in Germany to launch a study evaluating the effectiveness of SmartPAN in pancreatic surgery. This post-market study aims to further explore SmartPAN’s ability to detect and prevent pancreatic fluid leakage following surgical procedures.Read the article at biostock.se: https://www.biostock.se/en/2025/03/magle-group-launches-multicenter-trial-with-pancreatic-leakage-indicator/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

BioStock: How Magle Group focus their use of DSM

The company aims to establish itself as a leader in life-changing healthcare innovations. Watch Justin Pierce, CEO and Helena Ossmer Thedius, Chief Marketing and Innovation Officer, explain their technology platform of degradable starch microspheres (DSM), serving as the base for development of new products, in BioStock Studio.Watch the interview at biostock.se /en/: https://www.biostock.se/?p=52215&preview=true This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe